AbbVie Seeks New Trial After $140M AndroGel Verdict

Published: 31/01/2018
AbbVie Seeks New Trial After $140M AndroGel Verdict
Source: WWW.LAW360.COM

AbbVie Inc. on Tuesday asked an Illinois federal judge for a new trial in the second bellwether case over claims the drugmaker failed to warn consumers about risks accompanying its testosterone treatment AndroGel, calling the $140 million verdict fatally inconsistent.

Read more
Related news
Comment